These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26264279)

  • 41. Synthesis of curcumin derivatives targeting androgen receptor for castration-resistant prostate cancer therapy.
    Liu J; Ni Y; Zhou K; Wu G; Hu L; Zhu T; Xu D; Hu H
    Chem Biol Drug Des; 2024 Jul; 104(1):e14583. PubMed ID: 38991995
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human β-defensin 2 may inhibit internalisation of bacillus Calmette-Guérin (BCG) in bladder cancer cells.
    Kim JH; Kim SJ; Lee KM; Chang IH
    BJU Int; 2013 Oct; 112(6):781-90. PubMed ID: 23819923
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Study on Toll-like receptors expression and cytokine production induced by bacillus Calmette-Guerin in human bladder cancer cell].
    Li X; Gong ZY; Li H; Wei Q; Shi M; Yang YR
    Zhonghua Wai Ke Za Zhi; 2004 Feb; 42(3):177-81. PubMed ID: 15062066
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antiproliferative effect of ASC-J9 delivered by PLGA nanoparticles against estrogen-dependent breast cancer cells.
    Verderio P; Pandolfi L; Mazzucchelli S; Marinozzi MR; Vanna R; Gramatica F; Corsi F; Colombo M; Morasso C; Prosperi D
    Mol Pharm; 2014 Aug; 11(8):2864-75. PubMed ID: 24945469
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Secondary stimulation from Bacillus Calmette-Guérin induced macrophages induce nitric oxide independent cell-death in bladder cancer cells.
    Thiel T; Ryk C; Chatzakos V; Hallén Grufman K; Bavand-Chobot N; Flygare J; Wiklund NP; de Verdier PJ
    Cancer Lett; 2014 Jun; 348(1-2):119-25. PubMed ID: 24657658
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A mathematical model of combined bacillus Calmette-Guerin (BCG) and interleukin (IL)-2 immunotherapy of superficial bladder cancer.
    Bunimovich-Mendrazitsky S; Claude Gluckman J; Chaskalovic J
    J Theor Biol; 2011 May; 277(1):27-40. PubMed ID: 21334346
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Apoptosis Mechanism of Epirubicin Combined with BCG on Human Bladder Cancer Cells.
    Luo Y; Fu X; Han B; Zhang F; Yuan L; Men H; Zhang S; Tian S; Dong B; Meng M
    Anticancer Agents Med Chem; 2020; 20(13):1571-1581. PubMed ID: 32357825
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dihydrotestosterone upregulates the expression of epidermal growth factor receptor and ERBB2 in androgen receptor-positive bladder cancer cells.
    Zheng Y; Izumi K; Yao JL; Miyamoto H
    Endocr Relat Cancer; 2011 Aug; 18(4):451-64. PubMed ID: 21613411
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Maintenance Therapy with 3-monthly Bacillus Calmette-Guérin for 3 Years is Not Superior to Standard Induction Therapy in High-risk Non-muscle-invasive Urothelial Bladder Carcinoma: Final Results of Randomised CUETO Study 98013.
    Martínez-Piñeiro L; Portillo JA; Fernández JM; Zabala JA; Cadierno I; Moyano JL; Solsona E; Unda M; Beardo P; Rodríguez-Molina J; Chantada V; Palou J; Muntañola P; Alonso Dorrego JM; Pérez-Garcia FJ; Silva JM; Chesa N; Montesinos M; Ojea A; Madero R; Martínez-Piñeiro JA
    Eur Urol; 2015 Aug; 68(2):256-62. PubMed ID: 25794457
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CpG therapy is superior to BCG in an orthotopic bladder cancer model and generates CD4+ T-cell immunity.
    Mangsbo SM; Ninalga C; Essand M; Loskog A; Tötterman TH
    J Immunother; 2008 Jan; 31(1):34-42. PubMed ID: 18157010
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acquisition of agonistic properties of nonsteroidal antiandrogens after treatment with oncostatin M in prostate cancer cells.
    Godoy-Tundidor S; Hobisch A; Pfeil K; Bartsch G; Culig Z
    Clin Cancer Res; 2002 Jul; 8(7):2356-61. PubMed ID: 12114440
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of age on the efficacy of maintenance bacillus Calmette-Guérin relative to maintenance epirubicin in patients with stage Ta T1 urothelial bladder cancer: results from EORTC genito-urinary group study 30911.
    Oddens JR; Sylvester RJ; Brausi MA; Kirkels WJ; van de Beek C; van Andel G; de Reijke TM; Prescott S; Witjes JA; Oosterlinck W
    Eur Urol; 2014 Oct; 66(4):694-701. PubMed ID: 24948466
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Docetaxel suppresses immunotherapy efficacy of natural killer cells toward castration-resistant prostate cancer cells via altering androgen receptor-lectin-like transcript 1 signals.
    Tang M; Gao S; Zhang L; Liu B; Li J; Wang Z; Zhang W
    Prostate; 2020 Jul; 80(10):742-752. PubMed ID: 32449811
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bacille-Calmette Guèrin induces caspase-independent cell death in urothelial carcinoma cells together with release of the necrosis-associated chemokine high molecular group box protein 1.
    See WA; Zhang G; Chen F; Cao Y; Langenstroer P; Sandlow J
    BJU Int; 2009 Jun; 103(12):1714-20. PubMed ID: 19154459
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A novel steroidal antiandrogen targeting wild type and mutant androgen receptors.
    Andrieu T; Bertolini R; Nichols SE; Setoud R; Frey FJ; Baker ME; Frey BM
    Biochem Pharmacol; 2011 Dec; 82(11):1651-62. PubMed ID: 21907706
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeting androgen receptor versus targeting androgens to suppress castration resistant prostate cancer.
    Guo C; Yeh S; Niu Y; Li G; Zheng J; Li L; Chang C
    Cancer Lett; 2017 Jul; 397():133-143. PubMed ID: 28323036
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intravesical Immunomodulatory Imiquimod Enhances Bacillus Calmette-Guérin Downregulation of Nonmuscle-invasive Bladder Cancer.
    Camargo JA; Passos GR; Ferrari KL; Billis A; Saad MJA; Reis LO
    Clin Genitourin Cancer; 2018 Jun; 16(3):e587-e593. PubMed ID: 29174504
    [TBL] [Abstract][Full Text] [Related]  

  • 58. FGFR3 Down-Regulation is Involved in bacillus Calmette-Guérin Induced Bladder Tumor Growth Inhibition.
    Langle YV; Belgorosky D; Prack McCormick B; Sahores A; Góngora A; Baldi A; Lanari C; Lamb C; Eiján AM
    J Urol; 2016 Jan; 195(1):188-97. PubMed ID: 26144336
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bacille Calmette-Guerin can induce cellular apoptosis of urothelial cancer directly through toll-like receptor 7 activation.
    Yu DS; Wu CL; Ping SY; Keng C; Shen KH
    Kaohsiung J Med Sci; 2015 Aug; 31(8):391-7. PubMed ID: 26228277
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The immunotherapeutic effects of recombinant Bacillus Calmette-Guérin resistant to antimicrobial peptides on bladder cancer cells.
    Cho MJ; Kim MJ; Kim K; Choi YW; Lee SJ; Whang YM; Chang IH
    Biochem Biophys Res Commun; 2019 Jan; 509(1):167-174. PubMed ID: 30579607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.